The Mycobacterium tuberculosis MmpL11 Cell Wall Lipid Transporter Is Important for Biofilm Formation, Intracellular Growth, and Nonreplicating Persistence

Infection and Immunity
Catherine C WrightGeorgiana E Purdy

Abstract

The mycobacterial cell wall is crucial to the host-pathogen interface, because it provides a barrier against antibiotics and the host immune response. In addition, cell wall lipids are mycobacterial virulence factors. Themycobacterialmembraneproteinlarge (MmpL) proteins are cell wall lipid transporters that are important for basic mycobacterial physiology andMycobacterium tuberculosispathogenesis. MmpL3 and MmpL11 are conserved across pathogenic and nonpathogenic mycobacteria, a feature consistent with an important role in the basic physiology of the bacterium. MmpL3 is essential and transports trehalose monomycolate to the mycobacterial surface. In this report, we characterize the role of MmpL11 inM. tuberculosis. M. tuberculosismmpL11mutants have altered biofilms associated with lower levels of mycolic acid wax ester and long-chain triacylglycerols than those for wild-type bacteria. While the growth rate of themmpL11mutant is similar to that of wild-typeM. tuberculosisin macrophages, the mutant exhibits impaired survival in anin vitrogranuloma model. Finally, we show that the survival or recovery of themmpL11mutant is impaired when it is incubated under conditions of nutrient and oxygen starvation. Our results suggest that Mm...Continue Reading

References

Jun 6, 1991·Nature·C K StoverG F Hatfull
Oct 1, 1969·Journal of Bacteriology·A BekierkunstE Lederer
Jan 1, 1995·Annual Review of Biochemistry·P J Brennan, H Nikaido
Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Sep 19, 2000·Infection and Immunity·O OlakanmiL S Schlesinger
Oct 14, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·R L PerezJ K Actor
Oct 9, 2002·Microbiology·Natalie J GartonMichael R Barer
May 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Scott E ConverseJeffery S Cox
Mar 6, 2004·The Journal of Biological Chemistry·Pilar DomenechClifton E Barry
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rachel E GeiselElizabeth R Rhoades
May 24, 2005·Infection and Immunity·Pilar DomenechClifton E Barry
Sep 26, 2007·PLoS Pathogens·Deborah A LewinsohnDavid M Lewinsohn
Mar 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amit K Pandey, Christopher M Sassetti
May 7, 2008·Antimicrobial Agents and Chemotherapy·Olga DanilchankaMichael Niederweis
Aug 18, 2009·Molecular Microbiology·Georgiana E PurdyDavid G Russell
Jul 3, 2010·EMBO Molecular Medicine·Mi-Jeong KimDavid G Russell
Nov 11, 2010·Molecular Microbiology·Caroline DeshayesJean-Marc Reyrat
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Michael V TulliusCelia W Goulding
Oct 26, 2011·Antimicrobial Agents and Chemotherapy·Valentina La RosaEdda De Rossi
Feb 22, 2012·Nature Chemical Biology·Anna E GrzegorzewiczMary Jackson
Mar 1, 2012·ACS Chemical Biology·Sarah A GilmoreCarolyn R Bertozzi
Apr 24, 2012·Chemistry & Biology·Cristian VarelaApoorva Bhatt
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Dec 29, 2012·PloS One·Tatiana D SirakovaPappachan E Kolattukudy
Jun 12, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua T MattilaJoanne L Flynn

❮ Previous
Next ❯

Citations

Aug 31, 2017·The Journal of Membrane Biology·Ping LiJianping Xie
Sep 22, 2017·Infection and Immunity·Michael J Brennan
May 23, 2019·The Journal of Biological Chemistry·Prabhakar TiwariRamandeep Singh
Feb 19, 2020·PLoS Pathogens·Lei ZhangMichael Niederweis
Sep 20, 2019·Nature Communications·Avishek MitraMichael Niederweis
Sep 28, 2017·Archives of Microbiology·Padmani Sandhu, Yusuf Akhter
Apr 3, 2020·Journal of Microbiology and Biotechnology·Miguel Angel De la Cruz-VillegasJorge Bravo-Madrigal
May 25, 2021·Biofouling·Esmeralda Ivonne Niño-PadillaAdriana Garibay-Escobar
Aug 25, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Gift ChiwalaTianyu Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Transport Proteins

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacterial Transport Proteins (ASM)

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.